Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Touyun Biotech Group's share price for the quarter that ended in Dec. 2025 was HK$0.255. Touyun Biotech Group's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 2,805.59 Mil. Therefore, Touyun Biotech Group's market cap for the quarter that ended in Dec. 2025 was HK$715.43 Mil.
Touyun Biotech Group's quarterly market cap
declined
from Dec. 2024 (HK$521.91 Mil) to Jun. 2025 (HK$227.25 Mil) but then
increased
from Jun. 2025 (HK$227.25 Mil) to Dec. 2025 (HK$715.43 Mil).
Touyun Biotech Group's annual market cap
declined
from Dec. 2023 (HK$645.37 Mil) to Dec. 2024 (HK$521.91 Mil) but then
increased
from Dec. 2024 (HK$521.91 Mil) to Dec. 2025 (HK$715.43 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Touyun Biotech Group's Enterprise Value for Today is HK$955.58 Mil.
Touyun Biotech Group (HKSE:01332) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Touyun Biotech Group Market Cap Related Terms
Touyun Biotech Group Market Cap Historical Data
* Premium members only.
The historical data trend for Touyun Biotech Group's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaging & Containers subindustry, Touyun Biotech Group's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Touyun Biotech Group Market Cap vs Packaging & Containers Industry
For the Packaging & Containers industry and Consumer Cyclical sector, Touyun Biotech Group's Market Cap distribution charts can be found below:
* The bar in red indicates where Touyun Biotech Group's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Touyun Biotech Group's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Touyun Biotech Group (HKSE:01332) has a Market Cap of HK$448.90 Mil as of Jul. 20, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Touyun Biotech Group and its competitors. According to the industry distribution chart, Touyun Biotech Group ranks #205 out of 414 companies in the Packaging & Containers industry, placing it in the top 49.5%.
Is Touyun Biotech Group's Market Cap too high?
Touyun Biotech Group's current Market Cap is HK$448.90 Mil. Based on the distribution chart, Touyun Biotech Group ranks #205 out of 414 companies in the Packaging & Containers industry, which is above the industry midpoint. Overall, Touyun Biotech Group has a GF Score™ of 25/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Touyun Biotech Group's Market Cap compare to SW and PKG?
According to the Packaging & Containers industry distribution chart, Touyun Biotech Group ranks #205 out of 414 companies for Market Cap. This puts Touyun Biotech Group in the upper half of its industry. The industry median Market Cap is 57.95. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Packaging & Containers company?
The median Market Cap among Packaging & Containers companies is 57.95, based on 414 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Touyun Biotech Group and its competitors. For the Packaging & Containers industry, the median Market Cap is 57.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Touyun Biotech Group's current Market Cap is HK$448.90 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Touyun Biotech Group stock overvalued right now?
Based on GuruFocus' analysis, Touyun Biotech Group (HKSE:01332) is currently considered Fairly Valued. The stock's GF Value™ is HK$0.16, compared to a current price of HK$0.16 — trading right at its estimated fair value. The current Market Cap is HK$448.90 Mil. Touyun Biotech Group's overall GF Score™ is 25/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Touyun Biotech Group (HKSE:01332), the current Market Cap is HK$448.90 Mil as of Jul. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Touyun Biotech Group (HKSE:01332) Overvalued in 2026?
Based on GuruFocus' analysis, Touyun Biotech Group stock appears to be undervalued.
The current stock price of HK$0.16 is trading 0% below its estimated GF Value™ of HK$0.16.
GuruFocus considers Touyun Biotech Group to be Fairly Valued.
Key valuation signals for HKSE:01332:
Market Cap: HK$448.90 Mil
GF Value™: HK$0.16 vs. price of HK$0.16 (0% below fair value)
No single metric tells the full story. See the HKSE:01332 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Touyun Biotech Group Ltd is principally engaged in the (i) the manufacture and sale of packaging products; (ii) investments and trading in securities and money lending, and (iii) production and sale of Chlamydomonas reinhardtii, micro-algae and related products. The company generates majority of its revenue from packaging products segment.
25GF Score
Get the complete analysis for HKSE:01332
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01332 has been successfully added to your 
